Clinical Trial
doi: 10.1016/j.eurpsy.2004.06.035.
Is it worth while changing clinically stable schizophrenic out-patients with mild to moderate residual symptoms and/or side effects from conventional to atypical antipsychotics? A prospective, randomised study with olanzapine
Affiliations
- PMID: 15589715
- DOI: 10.1016/j.eurpsy.2004.06.035
Item in Clipboard
Clinical Trial
Is it worth while changing clinically stable schizophrenic out-patients with mild to moderate residual symptoms and/or side effects from conventional to atypical antipsychotics? A prospective, randomised study with olanzapine
Eur Psychiatry.
2004 Dec.
Abstract
Fifty clinically stable, schizophrenic outpatients, suffering from residual schizophrenic symptoms and/or neurological side effects, were randomised to either continue their conventional neuroleptic(s) or change it to olanzapine. After 12 weeks patients on olanzapine exhibited significant improvement in neurological side effects and psychotic symptomatology as compared to patients on conventional antipsychotics.
Similar articles
-
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Hum Psychopharmacol. 2011. PMID: 23055416 Review.
-
Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.J Clin Psychiatry. 2003 May;64(5):580-8. doi: 10.4088/jcp.v64n0514. J Clin Psychiatry. 2003. PMID: 12755663 Clinical Trial.
-
Olanzapine treatment of residual positive and negative symptoms.Am J Psychiatry. 2005 Jan;162(1):124-9. doi: 10.1176/appi.ajp.162.1.124. Am J Psychiatry. 2005. PMID: 15625210 Clinical Trial.
-
[A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].Neuropsychopharmacol Hung. 2007 Oct;9(3):115-24. Neuropsychopharmacol Hung. 2007. PMID: 18399029 Hungarian.
-
Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study.Schizophr Res. 2001 Mar 1;48(1):17-28. doi: 10.1016/s0920-9964(00)00112-2. Schizophr Res. 2001. PMID: 11278151 Review.
Cited by
-
Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.Cochrane Database Syst Rev. 2016 Apr 5;4(4):CD010631. doi: 10.1002/14651858.CD010631.pub2. Cochrane Database Syst Rev. 2016. PMID: 27045703 Free PMC article.
-
Schizophrenia with preserved insight is associated with increased perfusion of the precuneus.J Psychiatry Neurosci. 2012 Sep;37(5):297-304. doi: 10.1503/jpn.110125. J Psychiatry Neurosci. 2012. PMID: 22498076 Free PMC article.
-
Switching antipsychotics versus continued current treatment in people with non-responsive schizophrenia.Cochrane Database Syst Rev. 2025 Apr 11;4(4):CD011885. doi: 10.1002/14651858.CD011885.pub2. Cochrane Database Syst Rev. 2025. PMID: 40214650
-
Neural substrate of quality of life in patients with schizophrenia: a magnetisation transfer imaging study.Sci Rep. 2015 Dec 3;5:17650. doi: 10.1038/srep17650. Sci Rep. 2015. PMID: 26632639 Free PMC article. Clinical Trial.
-
Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.Eur Arch Psychiatry Clin Neurosci. 2017 Aug;267(5):465-472. doi: 10.1007/s00406-017-0771-4. Epub 2017 Feb 25. Eur Arch Psychiatry Clin Neurosci. 2017. PMID: 28238173
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
